4.2 Article

Effects of tofacitinib on nucleic acid metabolism in human articular chondrocytes

Related references

Note: Only part of the references are listed.
Article Rheumatology

JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical

Yoshiya Tanaka et al.

Modern Rheumatology (2014)

Article Rheumatology

Janus kinase inhibitors in autoimmune diseases

John J. O'Shea et al.

ANNALS OF THE RHEUMATIC DISEASES (2013)

Review Endocrinology & Metabolism

Adenosine and bone metabolism

Aranzazu Mediero et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)

Article Pharmacology & Pharmacy

Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease

Apostolos Kontzias et al.

CURRENT OPINION IN PHARMACOLOGY (2012)

Article Medicine, General & Internal

Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis

Roy Fleischmann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

Ronald F. van Vollenhoven et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Rheumatology

Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis

Anthony J. Milici et al.

ARTHRITIS RESEARCH & THERAPY (2008)

Review Biochemistry & Molecular Biology

Cytokine signaling in 2002: New surprises in the Jak/Stat pathway

JJ O'Shea et al.